Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Qiagen Names SVPs for New Business Units

Premium

Qiagen today announced organizational changes that include the creation of two new business areas, Molecular Diagnostics and Life Sciences, which will become operational on July 1.

CEO Peer Schatz announced the changes during a conference call recapping the company's first-quarter 2012 financial results.

As part of the changes, new executive committee member Helge Lubenow has been appointed senior vice president of the Molecular Diagnostics unit. Lubenow has been with Qiagen since 1997 and is currently vice president of molecular diagnostics marketing.

Dietrich Hauffe, also a new executive committee member, has been appointed senior vice president of the Life Sciences unit. He is currently VP of life sciences marketing.

Joachim Schorr, managing director and senior VP of global research and development, is leaving Qiagen, but will provide consulting services for the firm, the company said. He will depart during the second quarter.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.